Published in Cell on August 11, 2006
Transmissible [corrected] dog cancer genome reveals the origin and history of an ancient cell lineage. Science (2014) 2.58
The Tasmanian devil transcriptome reveals Schwann cell origins of a clonally transmissible cancer. Science (2010) 2.53
Genome sequencing and analysis of the Tasmanian devil and its transmissible cancer. Cell (2012) 2.37
Transmission of a fatal clonal tumor by biting occurs due to depleted MHC diversity in a threatened carnivorous marsupial. Proc Natl Acad Sci U S A (2007) 2.03
Horizontal transmission of clonal cancer cells causes leukemia in soft-shell clams. Cell (2015) 1.98
Widespread transmission of independent cancer lineages within multiple bivalve species. Nature (2016) 1.64
Analogies in the evolution of individual and social immunity. Philos Trans R Soc Lond B Biol Sci (2009) 1.53
Reversible epigenetic down-regulation of MHC molecules by devil facial tumour disease illustrates immune escape by a contagious cancer. Proc Natl Acad Sci U S A (2013) 1.45
Wildlife cancer: a conservation perspective. Nat Rev Cancer (2009) 1.31
Characterization of major histocompatibility complex class I and class II genes from the Tasmanian devil (Sarcophilus harrisii). Immunogenetics (2007) 1.28
100 years of Rous sarcoma virus. J Exp Med (2011) 1.24
Disease and the dynamics of extinction. Philos Trans R Soc Lond B Biol Sci (2012) 1.16
Immunologically silent cancer clone transmission from mother to offspring. Proc Natl Acad Sci U S A (2009) 1.07
Non-self recognition by monocytes initiates allograft rejection. J Clin Invest (2014) 1.06
The role of the Major Histocompatibility Complex in the spread of contagious cancers. Mamm Genome (2010) 1.03
Why Darwin would have loved evolutionary game theory. Proc Biol Sci (2016) 1.00
Longitudinal trends in climate drive flowering time clines in North American Arabidopsis thaliana. Ecol Evol (2012) 0.96
Cancer stem cells as 'units of selection'. Evol Appl (2012) 0.94
To lose both would look like carelessness: Tasmanian devil facial tumour disease. PLoS Biol (2006) 0.93
Comparative study of tumorigenesis and tumor immunity in invertebrates and nonmammalian vertebrates. Dev Comp Immunol (2010) 0.90
An expanding universe of the non-coding genome in cancer biology. Carcinogenesis (2014) 0.89
Immortality of cancers: a consequence of inherent karyotypic variations and selections for autonomy. Cell Cycle (2013) 0.89
Learning to get along despite struggling to get by. Genome Biol (2009) 0.89
Major Histocompatibility Complex (MHC) markers in conservation biology. Int J Mol Sci (2011) 0.89
The conundrum of causality in tumor virology: the cases of KSHV and MCV. Semin Cancer Biol (2013) 0.89
The changing global distribution and prevalence of canine transmissible venereal tumour. BMC Vet Res (2014) 0.88
Contagious cancer. Oncologist (2011) 0.88
Extensive conservation of genomic imbalances in canine transmissible venereal tumors (CTVT) detected by microarray-based CGH analysis. Chromosome Res (2009) 0.87
Comparison against 186 canid whole-genome sequences reveals survival strategies of an ancient clonally transmissible canine tumor. Genome Res (2015) 0.87
New lane in the information highway: alternative reading frame peptides elicit T cells with potent antiretrovirus activity. J Exp Med (2007) 0.86
Systems biology of cancer: entropy, disorder, and selection-driven evolution to independence, invasion and "swarm intelligence". Cancer Metastasis Rev (2013) 0.86
The innate immune system in transplantation. Semin Immunol (2011) 0.84
Cancer in the parasitic protozoans Trypanosoma brucei and Toxoplasma gondii. Proc Natl Acad Sci U S A (2015) 0.84
HLA antigen and NK cell activating ligand expression in malignant cells: a story of loss or acquisition. Semin Immunopathol (2011) 0.83
Mining the plasma immunopeptidome for cancer peptides as biomarkers and beyond. Proc Natl Acad Sci U S A (2010) 0.83
Immunology of naturally transmissible tumours. Immunology (2015) 0.82
Mitochondrial genetic diversity, selection and recombination in a canine transmissible cancer. Elife (2016) 0.82
Biphasic pulses enhance bleomycin efficacy in a spontaneous canine genital tumor model of chemoresistance: Sticker sarcoma. J Exp Clin Cancer Res (2008) 0.82
A tale of two tumours: comparison of the immune escape strategies of contagious cancers. Mol Immunol (2012) 0.81
Innate allorecognition. Immunol Rev (2014) 0.81
How the devil facial tumor disease escapes host immune responses. Oncoimmunology (2013) 0.81
Differences in cell division rates drive the evolution of terminal differentiation in microbes. PLoS Comput Biol (2012) 0.80
Using Nonlinear Stochastic Evolutionary Game Strategy to Model an Evolutionary Biological Network of Organ Carcinogenesis Under a Natural Selection Scheme. Evol Bioinform Online (2015) 0.80
Evolutionary perspective of cancer: myth, metaphors, and reality. Evol Appl (2015) 0.79
Transmission and expansion of HOXB4-induced leukemia in two immunosuppressed dogs: implications for a new canine leukemia model. Exp Hematol (2009) 0.79
A cheater lineage in a social insect: Implications for the evolution of cooperation in the wild. Commun Integr Biol (2009) 0.79
The singular history of a canine transmissible tumor. Cell (2006) 0.79
Weird genotypes? Don't discard them, transmissible cancer could be an explanation. Evol Appl (2016) 0.78
MHC variability supports dog domestication from a large number of wolves: high diversity in Asia. Heredity (Edinb) (2012) 0.78
Testing the theory of immune selection in cancers that break the rules of transplantation. Cancer Immunol Immunother (2009) 0.78
Transmissible Tumors: Breaking the Cancer Paradigm. Trends Genet (2015) 0.78
TP53 Polymorphisms allow for genetic sub-grouping of the canine transmissible venereal tumor. J Vet Sci (2009) 0.77
Comment on: 'guidelines for the use of cell lines in biomedical research': human-to-human cancer transmission as a laboratory safety concern. Br J Cancer (2015) 0.77
Allorecognition and chimerism in an invertebrate model organism. Organogenesis (2008) 0.76
Storage and allogeneic transplantation of peripheral nerve using a green tea polyphenol solution in a canine model. J Brachial Plex Peripher Nerve Inj (2010) 0.76
Cancer. Hiding in plain view--an ancient dog in the modern world. Science (2014) 0.75
The evolution of a malignant dog. Evol Dev (2007) 0.75
Comparative Analysis of Immune Checkpoint Molecules and Their Potential Role in the Transmissible Tasmanian Devil Facial Tumor Disease. Front Immunol (2017) 0.75
A Sixth Modality of Infectious Disease: Contagious Cancer from Devils to Clams and Beyond. PLoS Pathog (2016) 0.75
Overexpression of chemokine ligand 7 is associated with the progression of canine transmissible venereal tumor. BMC Vet Res (2012) 0.75
A la Pêche aux Moules. J Cell Commun Signal (2016) 0.75
Cell-based polymerase chain reaction for canine transmissible venereal tumor (CTVT) diagnosis. J Vet Med Sci (2016) 0.75
Regression of devil facial tumour disease following immunotherapy in immunised Tasmanian devils. Sci Rep (2017) 0.75
Demographic history, selection and functional diversity of the canine genome. Nat Rev Genet (2017) 0.75
No evidence for clonal transmission of urogenital carcinoma in California sea lions ( Zalophus californianus). Wellcome Open Res (2017) 0.75
Inference of population structure using multilocus genotype data. Genetics (2000) 147.76
Inference of population structure using multilocus genotype data: linked loci and correlated allele frequencies. Genetics (2003) 53.11
Multiple and ancient origins of the domestic dog. Science (1997) 27.18
Genome sequence, comparative analysis and haplotype structure of the domestic dog. Nature (2005) 23.04
Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol (2002) 14.75
THE RELATION OF RECOMBINATION TO MUTATIONAL ADVANCE. Mutat Res (1964) 11.15
Models of parasite virulence. Q Rev Biol (1996) 8.53
Genetic evidence for an East Asian origin of domestic dogs. Science (2002) 7.25
Genetic structure of the purebred domestic dog. Science (2004) 6.39
Natural selection of tumor variants in the generation of "tumor escape" phenotypes. Nat Immunol (2002) 5.75
Somatic cell parasitism and the evolution of somatic tissue compatibility. Proc Natl Acad Sci U S A (1982) 4.37
Allograft theory: transmission of devil facial-tumour disease. Nature (2006) 2.74
Dynamics of cancer progression. Nat Rev Cancer (2004) 2.64
Post-transplant Kaposi sarcoma originates from the seeding of donor-derived progenitors. Nat Med (2003) 2.61
Mutation patterns at dinucleotide microsatellite loci in humans. Am J Hum Genet (2002) 1.71
Genetic diversity and population structure of Tasmanian devils, the largest marsupial carnivore. Mol Ecol (2004) 1.65
Localized and disseminated histiocytic sarcoma of dendritic cell origin in dogs. Vet Pathol (2002) 1.57
"Retroposon" insertion into the cellular oncogene c-myc in canine transmissible venereal tumor. Proc Natl Acad Sci U S A (1985) 1.56
Fatal melanoma transferred in a donated kidney 16 years after melanoma surgery. N Engl J Med (2003) 1.53
CHROMOSOME STUDIES OF A CONTAGIOUS RETICULUM CELL SARCOMA OF THE SYRIAN HAMSTER. J Natl Cancer Inst (1964) 1.32
Unequal contribution of sexes in the origin of dog breeds. Genetics (2005) 1.26
Transplant tumor registry: donor related malignancies. Transplantation (2002) 1.19
Review of canine transmissible venereal sarcoma. Vet Res Commun (2000) 1.17
Common origin of transmissible venereal tumors (TVT) in dogs. Oncogene (1987) 1.13
Chromosome studies of a transplanted and a primary canine venereal sarcoma. J Natl Cancer Inst (1965) 1.09
MOSQUITO TRANSMISSION OF A RETICULUM CELL SARCOMA OF HAMSTERS. Science (1965) 1.09
mtDNA mutations in tumors of the central nervous system reflect the neutral evolution of mtDNA in populations. Oncogene (2004) 1.07
Extensive interbreed, but minimal intrabreed, variation of DLA class II alleles and haplotypes in dogs. Tissue Antigens (2002) 1.04
Tumor-infiltrating lymphocyte secretion of IL-6 antagonizes tumor-derived TGF-beta 1 and restores the lymphokine-activated killing activity. J Immunol (2004) 1.04
The canine transmissible venereal tumor: a unique result of tumor progression. Adv Cancer Res (1985) 1.03
Cancer causation: the Darwinian downside of past success? Lancet Oncol (2002) 1.01
MHC class II genes in European wolves: a comparison with dogs. Immunogenetics (2002) 1.01
[Considerations on the nature and studies of the ultrastructure of the Sticker sarcoma of the dog]. Bull Cancer (1968) 0.96
Genetic instability in human tumors. EXS (2006) 0.96
Evidence for extensive DLA polymorphism in different dog populations. Tissue Antigens (2002) 0.95
Genetic instability and the quasispecies model. J Theor Biol (2006) 0.94
Identification of canine transmissible venereal tumor cells using in situ polymerase chain reaction and the stable sequence of the long interspersed nuclear element. J Vet Diagn Invest (2003) 0.94
Lack of beta 2-microglobulin on the surface of canine transmissible venereal tumor cells. J Natl Cancer Inst (1984) 0.93
Primitive immune systems: are your ways my ways? Immunol Rev (2004) 0.92
A study of the cytology and karyotype of the canine transmissible venereal tumour. Res Vet Sci (1969) 0.92
Immunophenotype of the canine transmissible venereal tumour. Vet Immunol Immunopathol (1997) 0.92
A Line 1 insertion in the Factor IX gene segregates with mild hemophilia B in dogs. Mamm Genome (2003) 0.88
Chromosomal banding patterns in primary and transplanted venereal tumors of the dog. J Natl Cancer Inst (1973) 0.84
Proliferation characteristics of canine transmissible venereal tumor. Anticancer Res (2002) 0.84
Use of a murine xenograft model for canine transmissible venereal tumor. Am J Vet Res (2001) 0.81
Measurement of the rate of death of canine transmissible venereal tumour cells transplanted into dogs and nude mice. Res Vet Sci (1981) 0.81
Inference of population structure using multilocus genotype data: linked loci and correlated allele frequencies. Genetics (2003) 53.11
Genetic structure of human populations. Science (2002) 30.91
A map of recent positive selection in the human genome. PLoS Biol (2006) 29.19
A high-resolution survey of deletion polymorphism in the human genome. Nat Genet (2005) 16.99
Understanding mechanisms underlying human gene expression variation with RNA sequencing. Nature (2010) 16.86
A systematic survey of loss-of-function variants in human protein-coding genes. Science (2012) 12.25
Traces of human migrations in Helicobacter pylori populations. Science (2003) 11.92
Inferring weak population structure with the assistance of sample group information. Mol Ecol Resour (2009) 10.81
Inference of population structure using multilocus genotype data: dominant markers and null alleles. Mol Ecol Notes (2007) 10.11
High-resolution mapping of expression-QTLs yields insight into human gene regulation. PLoS Genet (2008) 9.68
Convergent adaptation of human lactase persistence in Africa and Europe. Nat Genet (2006) 9.44
A worldwide survey of haplotype variation and linkage disequilibrium in the human genome. Nat Genet (2006) 8.46
Signals of recent positive selection in a worldwide sample of human populations. Genome Res (2009) 8.38
Sequencing and analysis of Neanderthal genomic DNA. Science (2006) 8.06
Overcoming the winner's curse: estimating penetrance parameters from case-control data. Am J Hum Genet (2007) 6.99
Informativeness of genetic markers for inference of ancestry. Am J Hum Genet (2003) 6.90
Clines, clusters, and the effect of study design on the inference of human population structure. PLoS Genet (2005) 6.73
DNA methylation patterns associate with genetic and gene expression variation in HapMap cell lines. Genome Biol (2011) 6.48
DNase I sensitivity QTLs are a major determinant of human expression variation. Nature (2012) 6.17
Revealing the architecture of gene regulation: the promise of eQTL studies. Trends Genet (2008) 5.78
Analysis of memory B cell responses and isolation of novel monoclonal antibodies with neutralizing breadth from HIV-1-infected individuals. PLoS One (2010) 5.73
Effect of read-mapping biases on detecting allele-specific expression from RNA-sequencing data. Bioinformatics (2009) 5.62
Accurate inference of transcription factor binding from DNA sequence and chromatin accessibility data. Genome Res (2010) 5.40
Coalescent-based association mapping and fine mapping of complex trait loci. Genetics (2004) 5.26
Haplotype blocks and linkage disequilibrium in the human genome. Nat Rev Genet (2003) 5.16
High-resolution mapping of crossovers reveals extensive variation in fine-scale recombination patterns among humans. Science (2008) 5.02
Inference of population splits and mixtures from genome-wide allele frequency data. PLoS Genet (2012) 4.85
Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine. J Clin Invest (2010) 4.62
Duffy antigen receptor for chemokines mediates trans-infection of HIV-1 from red blood cells to target cells and affects HIV-AIDS susceptibility. Cell Host Microbe (2008) 4.55
Statistical tests for admixture mapping with case-control and cases-only data. Am J Hum Genet (2004) 4.52
Completing the map of human genetic variation. Nature (2007) 4.38
Confounding from cryptic relatedness in case-control association studies. PLoS Genet (2005) 3.61
The role of geography in human adaptation. PLoS Genet (2009) 3.41
Noisy splicing drives mRNA isoform diversity in human cells. PLoS Genet (2010) 3.19
Identification of genetic variants that affect histone modifications in human cells. Science (2013) 3.11
Human RNA "rumor" viruses: the search for novel human retroviruses in chronic disease. Microbiol Mol Biol Rev (2008) 3.07
Comment on "Widespread RNA and DNA sequence differences in the human transcriptome". Science (2012) 2.79
Adaptations to climate in candidate genes for common metabolic disorders. PLoS Genet (2008) 2.68
Genomics: ENCODE explained. Nature (2012) 2.62
Assessing the performance of the haplotype block model of linkage disequilibrium. Am J Hum Genet (2003) 2.59
Using environmental correlations to identify loci underlying local adaptation. Genetics (2010) 2.52
Dissecting the regulatory architecture of gene expression QTLs. Genome Biol (2012) 2.51
tRNAs promote nuclear import of HIV-1 intracellular reverse transcription complexes. PLoS Biol (2006) 2.28
DNA sequence-dependent compartmentalization and silencing of chromatin at the nuclear lamina. Cell (2012) 2.20
Primate transcript and protein expression levels evolve under compensatory selection pressures. Science (2013) 2.18
Adaptations to climate-mediated selective pressures in humans. PLoS Genet (2011) 2.15
Controls of nucleosome positioning in the human genome. PLoS Genet (2012) 2.14
A genome-wide study of DNA methylation patterns and gene expression levels in multiple human and chimpanzee tissues. PLoS Genet (2011) 1.92
A sensitive retroviral pseudotype assay for influenza H5N1-neutralizing antibodies. Influenza Other Respir Viruses (2007) 1.92
Evidence for extensive transmission distortion in the human genome. Am J Hum Genet (2003) 1.86
False positive peaks in ChIP-seq and other sequencing-based functional assays caused by unannotated high copy number regions. Bioinformatics (2011) 1.85
Kaposi's sarcoma-associated herpesvirus-infected primary effusion lymphoma has a plasma cell gene expression profile. Proc Natl Acad Sci U S A (2003) 1.84
Efficient counting of k-mers in DNA sequences using a bloom filter. BMC Bioinformatics (2011) 1.76
Llama antibody fragments with cross-subtype human immunodeficiency virus type 1 (HIV-1)-neutralizing properties and high affinity for HIV-1 gp120. J Virol (2008) 1.71
Prevalence and mechanisms of low- and high-level mupirocin resistance in staphylococci isolated from a Korean hospital. J Antimicrob Chemother (2003) 1.69
Gene expression levels are a target of recent natural selection in the human genome. Mol Biol Evol (2008) 1.63
Neutralizing antibodies to HIV-1 induced by immunization. J Exp Med (2013) 1.59
Natural selection affects multiple aspects of genetic variation at putatively neutral sites across the human genome. PLoS Genet (2011) 1.54
The Duffy-null state is associated with a survival advantage in leukopenic HIV-infected persons of African ancestry. Blood (2009) 1.51
Origins of HIV and the evolution of resistance to AIDS. Science (2006) 1.49
Depression and Internet addiction in adolescents. Psychopathology (2007) 1.47
Adaptive evolution of conserved noncoding elements in mammals. PLoS Genet (2007) 1.45
Emerging technologies for the detection of rabies virus: challenges and hopes in the 21st century. PLoS Negl Trop Dis (2009) 1.40
Transportin 3 promotes a nuclear maturation step required for efficient HIV-1 integration. PLoS Pathog (2011) 1.39
Characterizing natural variation using next-generation sequencing technologies. Trends Genet (2009) 1.39
The genetic architecture of adaptations to high altitude in Ethiopia. PLoS Genet (2012) 1.38
Comparative RNA sequencing reveals substantial genetic variation in endangered primates. Genome Res (2011) 1.36
Longitudinally profiling neutralizing antibody response to SARS coronavirus with pseudotypes. Emerg Infect Dis (2005) 1.36
Molecular epidemiology of Japanese encephalitis virus circulating in South Korea, 1983-2005. Virol J (2010) 1.35
Prevalence of tick-borne encephalitis virus in ticks from southern Korea. J Vet Sci (2010) 1.30
Investigating antibody neutralization of lyssaviruses using lentiviral pseudotypes: a cross-species comparison. J Gen Virol (2008) 1.27
Structural analyses of purified human immunodeficiency virus type 1 intracellular reverse transcription complexes. J Virol (2003) 1.27
AIDS/HIV. A boost for HIV vaccine design. Science (2010) 1.25
The contribution of RNA decay quantitative trait loci to inter-individual variation in steady-state gene expression levels. PLoS Genet (2012) 1.25
Identification of receptors for pig endogenous retrovirus. Proc Natl Acad Sci U S A (2003) 1.23
Potent and broad neutralization of HIV-1 by a llama antibody elicited by immunization. J Exp Med (2012) 1.23
Llama-derived single domain antibodies to build multivalent, superpotent and broadened neutralizing anti-viral molecules. PLoS One (2011) 1.20
HIV-1 exploits importin 7 to maximize nuclear import of its DNA genome. Retrovirology (2009) 1.20
PCR-based cloning and immunocytological titration of infectious porcine endogenous retrovirus subgroup A and B. J Gen Virol (2002) 1.14
Characterization of Moloney murine leukemia virus p12 mutants blocked during early events of infection. J Virol (2002) 1.13
The promiscuous CC chemokine receptor D6 is a functional coreceptor for primary isolates of human immunodeficiency virus type 1 (HIV-1) and HIV-2 on astrocytes. J Virol (2005) 1.11
Myogenic cell proliferation and generation of a reversible tumorigenic phenotype are triggered by preirradiation of the recipient site. J Cell Biol (2002) 1.10
Haplotype variation and genotype imputation in African populations. Genet Epidemiol (2011) 1.10
Duffy-null-associated low neutrophil counts influence HIV-1 susceptibility in high-risk South African black women. Clin Infect Dis (2011) 1.09
Haplotypic background of a private allele at high frequency in the Americas. Mol Biol Evol (2009) 1.08
A genome sequence resource for the aye-aye (Daubentonia madagascariensis), a nocturnal lemur from Madagascar. Genome Biol Evol (2011) 1.07
Nuclear import of viral DNA genomes. Traffic (2003) 1.06
Hyperthermia stimulates HIV-1 replication. PLoS Pathog (2012) 1.04
T cell responses to whole SARS coronavirus in humans. J Immunol (2008) 1.03
Inhibition of HIV-1 replication by isoxazolidine and isoxazole sulfonamides. Chem Biol Drug Des (2010) 1.02
On HIV diversity. AIDS (2012) 1.01
CD4-dependent and CD4-independent HIV-2: consequences for neutralization. AIDS (2003) 1.01
Virus neutralising activity of African fruit bat (Eidolon helvum) sera against emerging lyssaviruses. Virology (2010) 1.00
Novel endogenous retrovirus in rabbits previously reported as human retrovirus 5. J Virol (2002) 1.00
Exon-specific QTLs skew the inferred distribution of expression QTLs detected using gene expression array data. PLoS One (2012) 0.98
Generation of a family-specific phage library of llama single chain antibody fragments that neutralize HIV-1. J Biol Chem (2010) 0.98
Structural basis for nuclear import of splicing factors by human Transportin 3. Proc Natl Acad Sci U S A (2014) 0.98
A gp41 MPER-specific llama VHH requires a hydrophobic CDR3 for neutralization but not for antigen recognition. PLoS Pathog (2013) 0.97
A robust lentiviral pseudotype neutralisation assay for in-field serosurveillance of rabies and lyssaviruses in Africa. Vaccine (2009) 0.97